Republic of the Philippines
Department of Health
OFFICE OF THE SECRETARY 
San Lazaro Compound, Rizal Avenue 
Sta. Cruz, Manila, Philippines
Tel. No. 711-95-02/711-95-03

<date>08/09/2000</date>

<doctype>ADMINISTRATIVE ORDER</doctype>
<docnum>No. 99 s. 2000</docnum>

<subject>SUBJECT: BANNING AND WITHDRAWAL OF THE FIXED-DOSE-COMBINATION DRUG PRODUCT LORATADINE + PSEUDOEPHEDRINE (CLARINASE) FROM THE MARKET</subject>

<body>

In view of the findings and recommendations of the National Drug Committee of the Department of Health that:

1. The drug product Clarinase, containing a combination of Loratadine, an antihistaminic drug + Pseudoephedrine, a drug which has abuse potential, does not comply with the provisions and criteria cited under DOH-A.O. 96 s. 1990 re : “Guidelines on the Registration of Fixed-Dose-Combination Drug Products”.
2.The above—mentioned ﬁxed-dose-combination product is likewise not allowed under the 1997 Dangerous Drugs Board Resolution
3. Pseudoephedrine is under the control of the Dangerous Drugs Board and is included in Table 1, (chemicals and substances that are precursors to the manufacture of narcotics and psychotropic substances) of the 1988
UN Convention of the International Narcotics Control Board (INCB)

Therefore, in the interest of consumer protection, it is hereby ordered that:

1. The ﬁxed-dose-combination product Pseudoephedrine + Loratadine (Clarinase) shall no longer be registrable
2. The registration of Pseudoephedrine + Loratadine (Clarinase) be recalled and cancelled
3. The importer/distributor immediately withdraw all existing stocks from drugstores, hospitals, etc.

This order shall take effect immediately.

</body> 
<sign>ALBERTO G. ROMUALDEZ, JR., M.D</sign>
<signtitle>Secretary of Health</signtitle>